Skip to content

CARE Ratings Limited (CARERATING)

Small Cap

Financial Services stocks · Small cap · NSE

CARE Ratings Limited operates in Ratings, within the Financial Services sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹1,616.3
+12.40 · +0.77%
Market cap ₹4,836 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result16 Aug, 01:01 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Financial Services P/E 17.0 (n=243)
Technical timing lens

Trend score and candlestick chart

43Neutral

SMA20 -4.9% / mo · MACD +

Stock trend: 42
Sector RS: 44
Sector 3M: -5.8% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

CARERATINGD candles · FIT view+3.6%
Latest close ₹1616.30 on 2026-10-19
Bar
+1.3%
RSI
51
MACD hist
5.21
52W pos
50%
Visible chart range
Candle interval
2026-10-19O ₹1595.00H ₹1639.00L ₹1595.00C ₹1616.30Vol 1.1L sh
₹1.47k₹1.56k₹1.66k₹1.76k₹1.86k52H₹1616.302026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

CARERATINGNifty Financial ServicesNifty 500
-10%-5%+1%+6%20 Jul1 Sept19 Oct19 Oct 2026CARERATING -3.3%Nifty Financial Servi… -6.0%Nifty 500 -5.6%
CARERATING
-3.3%
Nifty 500
-5.6%
Nifty Financial Services
-6.0%
Vs Nifty 500
+2.3 pp
Chart stats
19 Oct 2026
From 52W high
-12.1%
₹1,838
52W range position
50%
₹1,392.7 - ₹1,838
ATR (14)
3.0%
₹48.8
Volume vs 20D
2.32x
Latest completed session
Avg traded value
₹8.3 Cr
20-session average
20D price channel
₹1,484.4 - ₹1,666.3
29.0% annualized volatility
Research snapshot

What the evidence says now

Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · FAIR VALUE
51

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
80

Revenue +19.1% · PAT +26.9% YoY

Technical
Neutral
43

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-7.1%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
85

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Excellent · 80/100

Rev +19% YoY · PAT +27% YoY · margin expansion · operating leverage

Filed 30 Jun 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹112 Cr+19.1%-14.5%
EBITDA₹35 Cr+25.0%-42.6%
Operating margin31.0%+100 bps-1500 bps
PAT₹33 Cr+26.9%-37.7%
PAT margin29.5%+180 bps-1100 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
27.20
P/B
5.19
EV/EBITDA
22.20
Market Cap
4836.00Cr

Profitability

ROE
19.70%
ROCE
26.30%
ROA
16.29%
Dividend Y
1.37%

Growth (CAGR)

Revenue 5Y
14.00%
EPS 5Y
14.00%
Revenue 3Y
19.00%
EPS 3Y
27.00%

Balance Sheet

Debt/Equity
0.03
Interest Coverage
102.00×
Altman Z
8.50
Book Value
310.00

Cash Flow

FCF Yield
1.12%
FCF Positive Y
12/5
OCF
148.00 Cr
EPS TTM
59.16

Shareholding

Promoter Hold
—
Promoter Pledge
0.00%
Momentum 52W
48%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 473+17.7% vs prev
0473.0Mar 2017: 287Mar 2018: 333Mar 2019: 319Mar 2020: 244Mar 2021: 248Mar 2022: 248Mar 2023: 279Mar 2024: 332Mar 2025: 402Mar 2026: 473FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: 174+24.3% vs prev
0174.0Mar 2017: 148Mar 2018: 162Mar 2019: 138Mar 2020: 83.0Mar 2021: 91.0Mar 2022: 77.0Mar 2023: 85.0Mar 2024: 103Mar 2025: 140Mar 2026: 174FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Return on Equity

%
Latest: 18.7+7.5% vs prev
028.5Mar 2017: 28.5%Mar 2018: 27.2%Mar 2019: 25.1%Mar 2020: 15.6%Mar 2021: 15.5%Mar 2022: 11.9%Mar 2023: 12.6%Mar 2024: 14.4%Mar 2025: 17.4%Mar 2026: 18.7%FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 51. Wait for confirmation.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 falling (~5.1% over last month) — short-term momentum negative.
  • RSI(14) at 51 — rising, no extreme reading.
  • MACD above signal, histogram expanding — bullish momentum building.
  • 12% off 52W high · 16% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

66
RS percentile
Stage 1 Base / Transition
1M return
-3.1%
3M return
-3.3%
6M return
+0.6%
1Y return
+4.5%
RS 1D
+4
RS 20D
+7
Sector rank
#10
Industry rank
-
Stage evidence
  • Price is within 1.5% of the 30-week proxy.
  • The 30-week proxy changed +0.0% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price below
Sector
weakening
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 106.85+1.82%
8996103111118Sept 25Feb 26Jun 26Oct 26107
RS vs Nifty 500107

Valuation & peers

U-Score 51 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies

51U-SCORE
Premium Compounder

Fundamental score breakdown

U band · FAIR VALUE
Valuation0/30
Growth16/25
Quality16/20
Balance Sheet9/15
Cash Flow5/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
51

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

51/100 · legacy band FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Quality contributes 16/20 to the score.
  • Growth contributes 16/25 to the score.

Main drags

  • Fair-value margin of safety is negative at -7.1%.
  • Valuation is weaker at 0/30; verify the latest quarterly trend.
  • Cash flow is weaker at 5/10; verify the latest quarterly trend.
Sector valuation model

Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks

For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.

Blended relative
Primary lens
PE, EV/EBITDA, margin of safety, and FCF yield together.
Secondary checks
ROE/ROCE, growth, cash conversion, leverage, promoter risk.
Main risk check
One cheap metric is not enough if quality or cash flow is weak.
PE
27.2
PB
5.2
EV/EBITDA
22.2
ROE
19.7%
ROCE
26.3%
FCF Yield
1.1%
Debt/Equity
0.0
MoS
-7.1%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
51
Previous: 51
Legacy U-Score band
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
-7.1%
Previous: -7.1%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
51
51
51
51
53
53
51
51
51
51
51
51

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹642.37
-151.6% MoS
Growth-justified P/E
25.5
Growth-justified Value
₹1,508.58
-7.1% MoS
PEG
1.42

Comparable companies

Peers

Business-comparable peers in Financial Services — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
ICRA
Small
ICRA Limited
Ratings
match 88
55
21.1
16.7%
+13%
FAIR VALUE
CRISIL
Large
CRISIL Limited
Ratings
match 66
53
37.1
24.5%
-47%
FAIR VALUE
MASFIN
Small
MAS Financial Services Limited
NBFC / Capital Markets / Insurance
match 19
41
12.2
13.4%
+52%
WATCHLIST
NORTHARC
Small
Northern Arc Capital Limited
NBFC / Capital Markets / Insurance
match 19
44
10.7
11.1%
+60%
WATCHLIST
PILANIINVS
Small
Pilani Investment and Industries Corporation Limited
Insurance
match 18
37
—
0.2%
-40%
WATCHLIST

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

CARE Ratings Limited operates in Ratings, within the Financial Services sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
85Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 98th percentile of the scored universe and 99th percentile within Financial Services. No major sub-score weakness stands out.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
123 docs text-extracted · 12 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
98th percentile

overall median 67 · Financial Services: 99th pctile, median 62 · Small: 99th pctile, median 66

Evidence depth
Financial-only

123 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
98
strong · capital discipline
Results
77
strong · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸FCF yield is positive at 1%.
  • ▸12 years of positive FCF.
  • ▸Debt/equity is 0.03.

Trust risks

  • ▸OPM spread across recent quarters is 20%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

12 shown
Announcement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 5 Oct - Allotment of 14,200 Equity shares pursuant to exercise of ESOP

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 24 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 11 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 2 Sep - Allotment of 24,500 equity shares pursuant to exercise of ESOP

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Aug

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Aug

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Aug

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Aug

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Aug

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.